That would have been part of the consideration for taking the product to market directly, that has been mentioned for a number of years. The posts are not that old covering that. Might have been why significant chunks of cash were drawn from funds borrowed early this year, around the primary end point being met for 28 day results.
Ann: Day 180 Survival Outcomes In aGvHD Phase 3 Trial, page-40
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.025(2.15%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $1.107M | 947.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 199671 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 37944 | 2 |
View Market Depth
| Last trade - 10.51am 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |